Medartis Holding AG / Key word(s): Annual Results/Forecast PRESS RELEASE Release of an ad hoc announcement pursuant to Art. 53 LR. The issuer is solely responsible for the content of this announcement.
<div><p>
</p><p><strong>FULL-YEAR 2024 KEY FINANCIALS</strong><br/><strong> </strong></p><table cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span>in CHF million, </span></span></p></td><td style="vertical-align: middle;"><p><span><span> </span></span></p></td><td style="vertical-align: middle;"><p><span><span>FY 2024 </span></span></p></td><td style="vertical-align: middle;"><p><span><span> </span></span></p></td><td style="vertical-align: middle;"><p><span><span> </span></span></p></td><td style="vertical-align: middle;"><p><span><span>FY 2023 </span></span></p></td><td style="vertical-align: middle;"><p><span><span> </span></span></p></td><td colspan="2" style="vertical-align: middle;"><p><span><span>yoy change, core </span></span></p></td></tr><tr><td style="vertical-align: top; width: 15%;"><p><span><span>rounded </span></span></p></td><td style="vertical-align: top;"><p><span><span>Reported </span></span></p></td><td style="vertical-align: top;"><p><span><span>Non-core items<sup>2</sup></span></span></p></td><td style="vertical-align: top;"><p><span><span>Core </span></span></p></td><td style="vertical-align: top;"><p><span><span>Restated<sup>3</sup></span></span></p></td><td style="vertical-align: top;"><p><span><span>Non-core items<sup>2</sup></span></span></p></td><td style="vertical-align: top;"><p><span><span>Core </span></span></p></td><td style="vertical-align: top;"><p><span><span>in CHF </span></span></p></td><td style="vertical-align: top;"><p><span><span>at CER </span></span></p></td></tr><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span>Net sales </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>224.8 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>(5.2) </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>219.6 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>212.0 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>(10.8) </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>201.2 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>9.2% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>11.7% </span></span></p></td></tr><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span>Gross profit </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>178.7 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>3.1 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>181.7 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>167.6 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>(0.9) </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>166.7 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td></tr><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span>EBITDA </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>48.0 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>(6.3) </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>41.7 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>30.5 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>3.8 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>34.3 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td></tr><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span>EBIT </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>7.9 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>12.9 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>20.8 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>7.7 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>4.5 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>12.2 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td></tr><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span>Net profit / loss </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>3.5 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>7.9 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>11.4 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>0.6 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>3.6 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>4.2 </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td></tr><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td></tr><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span>Margins in % of sales </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td colspan="2" style="vertical-align: bottom;"><p><span><span>Change in %-points (PP) </span></span></p></td></tr><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span>Gross profit </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>79.5% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>82.8% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>79.0% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>82.9% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>(0.1 PP) </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>0.3 PP </span></span></p></td></tr><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span>EBITDA </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>21.4% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>19.0% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>14.4% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>17.1% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>1.9 PP </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>2.7 PP </span></span></p></td></tr><tr><td style="vertical-align: bottom; width: 15%;"><p><span><span>EBIT </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>3.5% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>9.5% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>3.6% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span> </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>6.1% </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>3.4 PP </span></span></p></td><td style="vertical-align: bottom;"><p><span><span>4.3 PP </span></span></p></td></tr></tbody></table><p> </p><p><span><span><span><sup>[1]</sup></span><span><sup>,2</sup></span> This media release and accompanying financial documents include alternative performance measures (APMs), referred to as 'core' figures. These metrics provide additional insight into Medartis' underlying performance. Core figures exclude certain one-time, non-recurring and extraordinary items or items related to M&A that distort the understanding of the company's ongoing operating performance. Additionally, the NSI contract manufacturing business is classified as non-strategic and therefore excluded from core sales calculations. If not otherwise stated, core sales growth rates are always shown at constant exchange rates (CER). For a detailed overview of all non-core events, please refer to p. 126ff of the Annual Report 2024. </span></span></p><p><span><span><span><sup>3 </sup></span><span>The financial figures 2023 have been restated. Please refer to note 2.3 for the details.</span></span></span></p><p>
</p><p>
</p><p><span><strong>Basel, 18 March 2025: Medartis Holding AG (MED:SW), </strong><strong>a leading orthopaedic company specialising in head and extremity surgery, </strong><strong>today reported total sales of CHF</strong><strong> </strong><strong>224.8</strong><strong> </strong><strong>million for the full year 2024, representing growth of 8.5% at constant exchange rates (CER). Core sales increased 11.7% and reached CHF 219.6 million. </strong><strong>EMEA and US operations emerged as key growth drivers, with both regions growing 17%. Thanks to this double-digit topline growth, the company's core EBITDA margin surged from 17.1% to 19.0%. Based on this momentum and with the help of further growth initiatives, Medartis' management expects core sales growth to accelerate to between 13-15% in 2025.</strong></span></p><p>
</p><p><span><strong>Matthias Schupp, CEO of Medartis</strong> since November 2024, comments on the result: "I am honoured to be part of this company and convinced of its potential to become the global leader in our core categories. The company has built an excellent reputation for product excellence and is highly valued by customers for its comprehensive portfolio and precision quality. In my first few months, I have met a very dedicated team. We are committed to providing our customers complete solutions, and our right to win in the market will be determined by innovative solutions, customer centricity, and enhanced digital offerings. By combining our premium offerings with targeted value propositions, we aim to capture additional growth opportunities across different market segments. This will be a multi-year journey, and our financial guidance for 2025 should be seen as a first step in this direction." </span></p><p><span> </span></p><p>
</p><p><strong>PERFORMANCE BY REGION AND PRODUCT CATEGORY</strong></p><p><strong> </strong></p><table cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="vertical-align: middle;"><p><span><span>Core sales in CHF million </span></span></p></td><td style="vertical-align: middle;"><p><span><span>FY 2024 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>FY 2023 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>Change in CHF </span></span></p></td><td style="vertical-align: middle;"><p><span><span>Change at CER </span></span></p></td></tr><tr><td style="vertical-align: middle;"><p><span><span>EMEA </span></span></p></td><td style="vertical-align: middle;"><p><span><span>122.8 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>106.5 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>15.4% </span></span></p></td><td style="vertical-align: middle;"><p><span><span>17.0% </span></span></p></td></tr><tr><td style="vertical-align: middle;"><p><span><span>US<sup>1</sup></span></span></p></td><td style="vertical-align: middle;"><p><span><span>47.1 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>41.1 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>14.7% </span></span></p></td><td style="vertical-align: middle;"><p><span><span>17.3% </span></span></p></td></tr><tr><td style="vertical-align: middle;"><p><span><span>APAC </span></span></p></td><td style="vertical-align: middle;"><p><span><span>31.1 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>31.5 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>-1.3% </span></span></p></td><td style="vertical-align: middle;"><p><span><span>1.2% </span></span></p></td></tr><tr><td style="vertical-align: middle;"><p><span><span>LATAM </span></span></p></td><td style="vertical-align: middle;"><p><span><span>18.5 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>22.2 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>-16.5% </span></span></p></td><td style="vertical-align: middle;"><p><span><span>-10.8% </span></span></p></td></tr><tr><td style="vertical-align: middle;"><p><span><span>Total Group </span></span></p></td><td style="vertical-align: middle;"><p><span><span>219.6 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>201.2 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>9.1% </span></span></p></td><td style="vertical-align: middle;"><p><span><span>11.7% </span></span></p></td></tr><tr><td colspan="5" style="vertical-align: middle;"><p><span><span><sup>1</sup> Core growth excluding the NSI contract manufacturing business </span></span></p></td></tr></tbody></table><p><span>Medartis delivered again substantial growth across its <strong>EMEA</strong> business in 2024, achieving a 17.0% increase in sales for the full year. Sales reached CHF 122.8 million, representing 56% of total Group revenue. The company delivered consistent performance across both half-year periods, with balanced growth across geographic markets and its three business areas. All subsidiaries achieved double-digit growth rates, while each product unit grew by more than 15%. The second half of 2024 saw particularly strong results in Spain, Poland and the UK. The distributor markets maintained steady progression with single-digit growth, primarily due to political unrest and the war in the Middle East. </span></p><p><strong> </strong></p><p><span>Across product segments, the Upper Extremities segment delivered strong results, driven by Medartis' wrist solutions and Keri Medical's portfolio. Sales of the TOUCH prosthesis nearly doubled compared to the previous year, driven by strong adoption among new surgeons and increased procedure volumes from existing users. The Keri Medical distribution business in Germany, Austria and the UK contributed one-third of the overall growth. The Lower Extremities division also saw significant growth, led by the Ankle Trauma system and CCS screw portfolio. The Head surgery segment progressed well through new customer acquisition and the successful migration of existing customers from the Modus 1 to Modus 2 system. The EMEA performance is particularly notable as it generates strong cash flow that supports strategic development in new markets and customer acquisition. </span></p><p>
</p><p><span> </span></p><table cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="vertical-align: middle;"><p><span><span>Core sales in CHF million </span></span></p></td><td style="vertical-align: middle;"><p><span><span>FY 2024 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>FY 2023 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>Change in CHF </span></span></p></td><td style="vertical-align: middle;"><p><span><span>Change at CER </span></span></p></td></tr><tr><td style="vertical-align: middle;"><p><span><span>Upper Extremities </span></span></p></td><td style="vertical-align: middle;"><p><span><span>148.2 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>137.2 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>8.0% </span></span></p></td><td style="vertical-align: middle;"><p><span><span>10.5% </span></span></p></td></tr><tr><td style="vertical-align: middle;"><p><span><span>Lower Extremities </span></span></p></td><td style="vertical-align: middle;"><p><span><span>40.7 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>35.4 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>14.8% </span></span></p></td><td style="vertical-align: middle;"><p><span><span>17.9% </span></span></p></td></tr><tr><td style="vertical-align: middle;"><p><span><span>CMF and Others<sup>1</sup></span></span></p></td><td style="vertical-align: middle;"><p><span><span>30.7 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>28.6 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>7.4% </span></span></p></td><td style="vertical-align: middle;"><p><span><span>10.5% </span></span></p></td></tr><tr><td style="vertical-align: middle;"><p><span><span>Total Group </span></span></p></td><td style="vertical-align: middle;"><p><span><span>219.6 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>201.2 </span></span></p></td><td style="vertical-align: middle;"><p><span><span>9.1% </span></span></p></td><td style="vertical-align: middle;"><p><span><span>11.7% </span></span></p></td></tr><tr><td colspan="5" style="vertical-align: middle;"><p><span><span><sup>1</sup> Core growth excluding the NSI contract manufacturing business </span></span></p></td></tr></tbody></table><p><span><strong> </strong></span></p><p>
</p><p><span><strong>Medartis records double-digit US growth and strengthens elbow portfolio</strong></span></p><p><span>Medartis' core business in the <strong>US </strong>achieved growth of 17.3% (CER) with sales reaching CHF 47.1 million (total sales: CHF 52.4 million), growing at approximately three times the market rate. As expected, the company's contract manufacturing business declined to CHF 5.3 million (2023: CHF 10.8 million), with these services being discontinued in the future to focus US production capacity on Medartis products. </span></p><p><span> </span></p><p><span>The company recorded double-digit growth across its product categories, with particularly strong performance in the CCS screw line and intramedullary nail. Field Orthopaedics' intramedullary nail portfolio has effectively complemented Medartis' hand portfolio, providing surgeons with additional fixation technology options. The distribution of Keri Medical products further contributed to this positive development. In a strategic move to strengthen its elbow portfolio, the company also announced the acquisition of the Avenger Radial Head System, an elbow prosthesis, from In2Bones Global, Inc., a wholly owned subsidiary of CONMED Corporation. With this acquisition, Medartis expands its capabilities in the upper extremities segment by adding joint replacement options to its existing reconstruction solutions for elbow procedures. Commercial distribution in the US market commenced in March 2025. </span></p><p><span> </span></p><p><span>The company appointed David Thoni as the new US President and member of the Executive Board in late 2024, and he took office in January 2025. Under his leadership, Medartis initiated a comprehensive review of its 57 distribution partners. In upper extremities, the company will focus on dealers exclusively dedicated to the Medartis brand. To date, the review has achieved half of the planned adjustments, with the remaining changes to be implemented in H1 2025. This strategic realignment aims to position Medartis for sustainable growth in the world's largest orthopaedic market. </span></p><p><span> </span></p><p><span>The <strong>APAC region</strong> achieved sales of CHF 31.1 million in 2024, representing modest growth of 1.2% (CER). In Australia, persisting challenging market conditions led to slightly declining sales despite further volume gains. The last of three mandated price adjustments in the private health sector impacted the company’s performance in 2024, with the final cut taking effect in July 2024. To counter this negative price effect, Medartis successfully launched Keri Medical's TOUCH prosthesis, which garnered strong interest from both existing and new surgeons. Due to the strong demand from surgeons for the first surgeon training programme in the third quarter of 2024, the company has begun the second wave of training in February 2025. </span></p><p><span> </span></p><p><span>In Japan, the company continued its transition to direct sales operations. Under the new leadership of Kenyu Kobayashi, an experienced Japanese General Manager, well-versed in the local orthopaedic market, the company is now expanding its sales and operations teams while strengthening both upper and lower extremity franchises. The offering includes sterile and non-sterile options, backed by an educational programme through IBRA partnership. </span></p><p><span>Finally, distributor sales in the greater APAC region developed well, with only Korean hospital staff strikes affecting the otherwise good performance. After a period of muted growth in the region, the company expects to return to a stronger performance in 2025, as the price effects in Australia will annualise by the middle of the year and the first positive effects of the business transition in Japan should become visible. </span></p><p><span><strong> </strong></span></p><p><span><strong>LATAM</strong> sales decreased by ‑10.8% (CER) to CHF 18.5 million due to challenging market conditions. Brazil, which represents approximately half of regional revenue, experienced a double-digit decline. This was driven by consolidation in the private insurance sector leading to increased reimbursement pressure, particularly affecting the premium segment for CMF procedures. Management implemented strategic measures at year-end, including price positioning reviews and tender contract renegotiations. Additional headwinds included delays in new product approvals from ANVISA, Brazil's regulatory authority. Mexico reached the prior year sales level despite reduced government procurement during the election period. The company expanded its presence in distributor markets Peru and Ecuador in Q3 with the successful launch of the Modus 2 CMF product line. </span></p><p><span> </span></p><p><span><strong>Entry into the large value segment in Latin America</strong></span></p><p><span>With the publication of today's results, Medartis also announced the acquisition of a 51% stake in NeoOrtho, a fast growing value player in the Brazilian orthopaedic market. The transaction will be funded primarily through existing cash reserves and bank facilities. Completion is expected by the end of April, with full consolidation of its sales commencing thereafter. Both companies have agreed on a clear path for Medartis to increase its ownership to 100% by 2028/29. The investment marks a strategic entry into the attractive value segment in Latin America, which currently accounts for an estimated 70-80% of the total market. NeoOrtho specialises in trauma, CMF and spine implants, with a focus on making tested surgical solutions more accessible to a broader population through competitive pricing in public hospital tenders. This acquisition is significant as it enables Medartis to implement a multi-tiering strategy in markets where its premium brand currently addresses only a limited segment of the total market. As part of the transaction, Medartis is acquiring a state-of-the-art modular production facility, scheduled to commence operations by the end of 2025. The strategic partnership also outlines opportunities for additional geographical expansion in the future. </span></p><p><span> </span></p><p><strong> </strong></p><p><strong>FINANCIAL PERFORMANCE</strong></p><p><span><strong> </strong></span></p><p><span>This media release and other investor and financial press communications include Alternative Performance Measures (APMs). The Medartis management uses these metrics to assess Medartis' financial and operational performance, providing a complementary perspective to standard financial figures as defined by IFRS. These APMs exclude one-time effects and intangible asset amortization from M&A projects that could distort understanding of the company's ongoing operating performance. </span></p><p><span> </span></p><p><span>In H2 2024, Medartis received an insurance payment of CHF 4.8 million to cover costs related to a cyber attack incident in summer June 2023. This payment was recorded under 'other operating income'. As previously communicated, Medartis released contingent consideration of CHF 6.9 million related to the NSI acquisition due to revised sales projections for the acquired technologies. Both unexpected gains were excluded from core financial metrics. In connection with the reassessment of these technologies, Medartis recognised an impairment charge of CHF 17.9 million in 'Research and development' and the book value of these intangible assets are now completely written off. 'Other provisions' include costs associated with the CEO transition (recruitment, contractually guaranteed salary continuation payments). These special costs, along with the contribution from the NSI third-party business (scheduled for phase-out in the future), have been excluded from the core results to provide a more accurate comparison of the recurring business performance. The following comments compare the core results for 2024 with those of the previous year. </span></p><p><span><strong> </strong></span></p><p><span>Medartis demonstrated improved profitability in 2024 across key financial metrics. Core <strong>gross profit</strong> decreased by 0.1PP (+0.3PP excluding FX effects), and the corresponding margin reached 82.8% - a high level compared to industry standards. This improvement was driven by a combination of higher sales and efficiency improvements in manufacturing. The reported gross profit increased just 6.6%, impacted by dilution of the third-party manufacturing activities and a one-time inventory write-off of CHF 2.3 million related to these products. </span></p><p><span> </span></p><p><span><strong>Operating expenses (OPEX)</strong> increased in line with the company's growth strategy. Distribution costs as a percentage of sales decreased from 48.3% to 46.4%. In 2024, the company invested primarily in sales, marketing and medical education programmes in the US. Logistics costs improved through enhanced cost control and efficiency gains. Excluding the aforementioned impairment charge, core R&D expenses remained fairly stable at CHF 24.6 million or 11.2% of sales. The share of the results from the associated company Keri Medical increased by slightly more than CHF 1 million. </span></p><p><span> </span></p><p><span>Operational performance strengthened significantly, with core <strong>EBITDA</strong> increasing from CHF 34.3 million to CHF 41.7 million and the respective EBITDA margin surging 1.9PP from 17.1% to 19.0%. The core <strong>EBIT</strong> margin also improved 3.4PP to 9.5% achieved through disciplined cost management, operational efficiencies, and a strategic focus on higher-margin product lines. </span></p><p><span> </span></p><p><span>Core <strong>net profit</strong> increased from CHF 4.2 million to CHF 11.4 million, supported by an improved financial result. Basic earnings per share increased from CHF 0.35 to 0.92. Free cash flow improved due to higher operating cash flow (+CHF 12.1 million) and despite inventory increasing by CHF 10.8 million, primarily attributed to set investments to drive future growth. Combined with net proceeds of CHF 112.4 million from the convertible bond placement in April, the company's <strong>cash position</strong> strengthened from CHF 25.2 million to CHF 138.7 million at year-end. These additional funding will be used for general purposes and to acquire the remaining shares in Keri Medical, where Medartis currently holds a 47% stake. </span></p><p><span> </span></p><p><span><strong> </strong></span></p><p><strong>FULL-YEAR 2025 OUTLOOK</strong></p><p><span><span style="text-transform: uppercase;">(barring any unforeseen circumstances)</span></span></p><p><span><strong> </strong></span></p><p><span>Medartis expects to strengthen its market position in the US in 2025, while making gradual progress in Japan and Australia. Based on these assumptions, the company expects organic growth in core sales<span><sup>4 </sup></span>of 13-15% in 2025. The company further expects to maintain its core EBITDA margin in the high teens, reflecting planned investments in growth initiatives and the strategic expansion of the TOUCH product portfolio in the US and Australian markets. </span></p><p><span> </span></p><p><span><strong>____________________________________________________________________________________</strong></span></p><p><span><strong> </strong></span></p><p>
</p><p><span><span style="text-transform: uppercase;"><strong>Medartis to Host Full-Year 2024 Results Conference with</strong></span><span style="text-transform: uppercase;"><strong>Q&A</strong></span></span></p><p>
</p><p><span><span>Medartis will present its full-year 2024 results today at 10:30 a.m. CET at its headquarters in Basel. The new CEO, Matthias Schupp, and CFO, Dirk Kirsten, will host the event. The conference will be held in English. The presentation materials, Annual Report and a recording of the event is available on the Medartis website (</span><span data-tobf='blank' data-lobf='v4fox4ar=NTAxlaImpT9vQWEyXR9wpoKmpyE=k8Ew7TBwBbHxNROxQVUnBqTxBj/vl8AmQeByl8Hdk6PmOiOmBmRm9mOa9aqn2fAbOA7mk6omBZoaOj9mk0A8B0Lx2MEmp0ovkTJlpA/dh6MaYZRch6BxpAonjTEnYPrwpRAmBTPxCbAlpbKwlRt19xMbYaPah3P=hxNnh6Ib2nBaNoRc2aL=hZqb9n5ahxMb2aomgn5x4WHvkb5y2AKwATJmkPAdkRAyQau'Out', 'eqs', '49356912');" class='js-l-obf link link--blue'><span><u>www.medartis.com</u></span></span><span>).</span></span></p><p><span>If you cannot attend in person, use the <span data-tobf='blank' data-lobf='v4fox4ar=NTAxlaImpT9vQWEyXR9wpoKmpyE=k8Ew7TBwBbHxNROxQVUnBqTxBj/vl8AmQeByl8Hdh89b2aRbBZMmBfAmhj/b9eompn/aBmLahaObk8/ahmN8B0Lx2MEmp0ovkTJlpA/dh6MaYZRch6BxpAonjTEnYPrwpRAmBTPxCbAlpbKwlRt19xMbYaPah3P=hxNnh6Ib2nBaNoRc2aL=hZqb9n5ahxMb2aomgn5x4WHvkb5y2AKwATJmkPAdkRAyQau'Out', 'eqs', '49356912');" class='js-l-obf link link--blue'><span><u>webcast link</u></span></span> to follow the slide presentation and submit questions in writing or via the webcast. </span></p><p><span><strong> </strong></span></p><p><span><strong>IMPORTANT DATES AND UPCOMING INVESTOR EVENTS</strong></span></p><p>
</p><table cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="vertical-align: top;"><p><span>Date </span></p></td><td style="vertical-align: top;"><p><span>Event </span></p></td><td style="vertical-align: top;"><p><span>Broker </span></p></td><td style="vertical-align: top;"><p><span>Destination </span></p></td></tr><tr><td style="vertical-align: top;"><p>
18 March</p></td><td style="vertical-align: top;"><p>
2024 full-year results publication</p></td><td style="vertical-align: top;"><p>
</p></td><td style="vertical-align: top;"><p>
Basel, hybrid</p></td></tr><tr><td style="vertical-align: top;"><p>
19 March</p></td><td style="vertical-align: top;"><p>
Investor meetings</p></td><td style="vertical-align: top;"><p>
ZKB</p></td><td style="vertical-align: top;"><p>
Zurich</p></td></tr><tr><td style="vertical-align: top;"><p>
20 March</p></td><td style="vertical-align: top;"><p>
Investor meetings</p></td><td style="vertical-align: top;"><p>
Stifel</p></td><td style="vertical-align: top;"><p>
London</p></td></tr><tr><td style="vertical-align: top;"><p>
25 April</p></td><td style="vertical-align: top;"><p>
Annual General Meeting 2025</p></td><td style="vertical-align: top;"><p>
</p></td><td style="vertical-align: top;"><p>
Basel, HQ</p></td></tr><tr><td style="vertical-align: top;"><p>
19 August</p></td><td style="vertical-align: top;"><p>
2025 half-year results publication</p></td><td style="vertical-align: top;"><p>
</p></td><td style="vertical-align: top;"><p>
Webcast</p></td></tr><tr><td style="vertical-align: top;"><p>
5-7 November</p></td><td style="vertical-align: top;"><p>
Swiss Equity Conference</p></td><td style="vertical-align: top;"><p>
ZKB</p></td><td style="vertical-align: top;"><p>
Zurich, CH</p></td></tr></tbody></table><p><strong> </strong></p><p><strong> </strong></p><p><span><strong>Your contact:</strong></span></p><p><span>Medartis Corporate Communications </span></p><p><span>Fabian Hildbrand, Head of Corporate Communications, investor.relations@medartis.com </span></p><p><span>Andreas Richter, Corporate Communications Manager, corporate.communication@medartis.com </span></p><p><span>+41 61 633 37 36 / +41 61 633 37 34 </span></p><p><span> </span></p><p><span><strong>About Medartis</strong></span></p><p><span>Founded in 1997 and headquartered in Basel, Switzerland, Medartis is one of the world’s leading manufacturers and providers of medical devices for surgical fixation of bone fractures for upper and lower extremities as well as for the craniomaxillofacial region. Medartis employs approx. 950 individuals across its 13 locations, with products offered in over 50 countries globally. Medartis is committed to providing surgeons and operating theatre personnel with the most innovative titanium implants and instruments as well as best-in-class service. For more information, please visit <span data-tobf='blank' data-lobf='v4fox4ar=NTAxlaImpT9vQWEyXR9wpoKmpyE=k8Ew7TBwBbHxNROxQVUnBqTxBj/vl8AmQeByl8Hdk6PmOiOmBmRm9mOa9aqn2fAbOA7mk6omBZoaOj9mk0A8B0Lx2MEmp0ovkTJlpA/dh6MaYZRch6BxpAonjTEnYPrwpRAmBTPxCbAlpbKwlRt19xMbYaPah3P=hxNnh6Ib2nBaNoRc2aL=hZqb9n5ahxMb2aomgn5x4WHvkb5y2AKwATJmkPAdkRAyQau'Out', 'eqs', '49356912');" class='js-l-obf link link--blue'><span><u>www.medartis.com</u></span></span>. </span></p><p><span> </span></p><p><span> </span></p><p><span><strong>Disclaimer</strong></span></p><p><span>This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Medartis Holding AG. This publication may contain certain forward-looking statements and assessments or intentions concerning the company and its business. Such statements involve certain risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of the company to be materially different from those expressed or implied by such statements. Readers should therefore not place reliance on these statements, particularly in connection with any contract or investment decision. The company disclaims any obligation to update these forward-looking statements, assessments or intentions. Furthermore, neither the company nor any of its directors, officers, employees, agents, counsel or advisers nor any other person makes any representation or warranty, express or implied, as to the accuracy or completeness of the information contained herein or of the views given or implied, and accordingly no reliance should be placed thereon. </span></p><p>
</p></div><hr style="width: 33%;"/><div id="_ftn1"><p>
</p></div><div id="_ftn2"><p><span><span><sup>4</sup> Excluding sales from NSI contract manufacturing business and other M&A. </span></span></p></div></div></div><br/><hr/>End of Inside Information<hr/></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" nowrap="nowrap">Language:</td><td align="left" valign="top">
English</td></tr><tr><td align="left" valign="top" nowrap="nowrap">Company:</td><td align="left" valign="top">
Medartis Holding AG </td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">
Hochbergerstrasse 60E</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">
4057 Basel</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">
Switzerland</td></tr><tr><td align="left" valign="top" nowrap="nowrap">Phone:</td><td align="left" valign="top">
+41 61 633 34 34</td></tr><tr><td align="left" valign="top" nowrap="nowrap">Fax:</td><td align="left" valign="top">
+41 61 633 34 00</td></tr><tr><td align="left" valign="top" nowrap="nowrap">E-mail:</td><td align="left" valign="top">
info@medartis.com</td></tr><tr><td align="left" valign="top" nowrap="nowrap">Internet:</td><td align="left" valign="top">
www.medartis.com</td></tr><tr><td align="left" valign="top" nowrap="nowrap">ISIN:</td><td align="left" valign="top">
CH0386200239</td></tr><tr><td align="left" valign="top" nowrap="nowrap">Valor:</td><td align="left" valign="top">
38620023</td></tr><tr><td align="left" valign="top">Listed:</td><td align="left" valign="top">
SIX Swiss Exchange</td></tr><tr><td align="left" valign="top" nowrap="nowrap">EQS News ID:</td><td align="left" valign="top">
2101992</td></tr></table><br/><table border="0" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" colspan="2"/></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td align="left" valign="top" colspan="2"> </td></tr><tr><td align="left" valign="top">End of Announcement</td><td align="left" valign="top">
EQS News Service</td></tr></table><table border="0" width="600" cellpadding="0" cellspacing="0"><tr><td><hr/></td></tr></table><p>
2101992 18-March-2025 CET/CEST
</p><img data-zoomable="true" src="https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2101992&application_name=news&site_id=zonebourse_com~~~71435185-72e2-4ff3-98c0-1866a1714c4a" alt="" width="0" height="0" border="0"/></p></div><div class="grid gbetween align-center mt-15"><div class="c-auto mb-15 txt-s2"><div></div>
© EQS -
2025
</div><div class="c-auto mb-15"><div class="dropdown-container "><span class="js_dropdown cursor-pointer c-inline " data-dropdown="#shareIt_47520"
><span class="px-15 py-10 btn btn--action--outter c-block"><i class="bi-box-arrow-up"></i> Share
</span></span><div id="shareIt_47520" class="dropdown "><div class="py-10 px-15"><div class="grid gnowrap" data-trans="Link copied"><a class="c-block c " target="popup" style="color:#0073b1"
href="https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FMEDARTIS-HOLDING-AG-42470802%2Fnews%2FMedartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912%2F%3Futm_source%3Dlinkedin%26utm_medium%3Dsocial%26utm_campaign%3Dshare&title=Medartis delivers 12%25 core sales growth in 2024 and improves its core EBITDA margin from 17%25 to 19%25&summary=Medartis Holding AG / Key word: Annual Results/Forecast
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19% 18-March-2025 / 06:59 CET/CEST
Release of...&source="
title="Share on LinkedIn"
rel="nofollow"
https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FMEDARTIS-HOLDING-AG-42470802%2Fnews%2FMedartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912%2F%3Futm_source%3Dlinkedin%26utm_medium%3Dsocial%26utm_campaign%3Dshare&title=Medartis delivers 12%25 core sales growth in 2024 and improves its core EBITDA margin from 17%25 to 19%25&summary=Medartis Holding AG / Key word: Annual Results/Forecast
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19% 18-March-2025 / 06:59 CET/CEST
Release of...&source=','popup','width=600,height=600'); return false;"
><i class="bi-linkedin txt-s4 px-5"></i></a><a class="c-block c " target="popup" style="color:#000"
href="https://x.com/intent/tweet?text=Medartis delivers 12%25 core sales growth in 2024 and improves its core EBITDA margin from 17%25 to 19%25%20%23MarketScreener&url=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FMEDARTIS-HOLDING-AG-42470802%2Fnews%2FMedartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912%2F%3Futm_source%3Dtwitter%26utm_medium%3Dsocial%26utm_campaign%3Dshare"
title="Share on X"
rel="nofollow"
https://x.com/intent/tweet?text=Medartis delivers 12%25 core sales growth in 2024 and improves its core EBITDA margin from 17%25 to 19%25%20%23MarketScreener&url=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FMEDARTIS-HOLDING-AG-42470802%2Fnews%2FMedartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912%2F%3Futm_source%3Dtwitter%26utm_medium%3Dsocial%26utm_campaign%3Dshare','popup','width=600,height=600'); return false;"
><i class="bi-twitter-x txt-s4 px-5"></i></a><a class="c-block c " target="popup" style="color:#25D366"
href="https://wa.me/?text=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FMEDARTIS-HOLDING-AG-42470802%2Fnews%2FMedartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912%2F%3Futm_source%3Dwhatsapp%26utm_medium%3Dsocial%26utm_campaign%3Dshare"
title="Share on WhatsApp"
rel="nofollow"
><i class="bi-whatsapp txt-s4 px-5"></i></a><a class="c-block c " target="popup" style="color:#0088cc"
href="https://telegram.me/share/url?url=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FMEDARTIS-HOLDING-AG-42470802%2Fnews%2FMedartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912%2F%3Futm_source%3Dtelegram%26utm_medium%3Dsocial%26utm_campaign%3Dshare"
title="Share on Telegram"
rel="nofollow"
><i class="bi-telegram txt-s4 px-5"></i></a><a class="c-block c " target="popup" style="color:#1877f2"
href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FMEDARTIS-HOLDING-AG-42470802%2Fnews%2FMedartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912%2F%3Futm_source%3Dfacebook%26utm_medium%3Dsocial%26utm_campaign%3Dshare"
title="Share on Facebook"
rel="nofollow"
https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FMEDARTIS-HOLDING-AG-42470802%2Fnews%2FMedartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912%2F%3Futm_source%3Dfacebook%26utm_medium%3Dsocial%26utm_campaign%3Dshare','popup','width=600,height=600'); return false;"
><i class="bi-facebook txt-s4 px-5"></i></a><a class="c-block c js-copyArticle" target="popup" style="color:#3a3a3a"
href="https://www.marketscreener.com/quote/stock/MEDARTIS-HOLDING-AG-42470802/news/Medartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912/?utm_source=copy&utm_medium=social&utm_campaign=share"
title="Share on Copy"
rel="nofollow"
><i class="bi-link-45deg txt-s4 px-5"></i></a><a class="c-block c " target="popup" style="color:#3a3a3a"
href="mailto:?subject=MarketScreener.com: Medartis delivers 12%25 core sales growth in 2024 and improves its core EBITDA margin from 17%25 to 19%25&body=Medartis delivers 12%25 core sales growth in 2024 and improves its core EBITDA margin from 17%25 to 19%25%0D%0A%0D%0AMedartis Holding AG / Key word: Annual Results/Forecast
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19% 18-March-2025 / 06:59 CET/CEST
Release of...%0D%0A%0D%0Ahttps%3A%2F%2Fwww.marketscreener.com%2Fquote%2Fstock%2FMEDARTIS-HOLDING-AG-42470802%2Fnews%2FMedartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912%2F%3Futm_source%3Demail%26utm_medium%3Dsocial%26utm_campaign%3Dshare"
title="Share on Email"
rel="nofollow"
><i class="bi-envelope-fill txt-s4 px-5"></i></a></div></div></div></div></div></div></article></div></div><div class="m-15" id="Zonebourse_Article_Video"><div
class="vsly-player media--169 bg-grey position-relative"
id="PLCHkFhqLGmYn"
data-template="PVaRF_MsC2XGj"></div></div><div class="mb-15 gcenter"><!-- VideoAnchor --><div class='zppAds'><div id='zppVideoAnchor'></div></div><script>
aAdsList.push('VideoAnchor');
aAdsListSize.push(null);
aAdsListCA.push(['US']);
</script></div><div class="card mb-15"><div class="card-header"><h3 class="card-title"><a class="link" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/news/">
Latest news about Medartis Holding AG </a></h3></div><div class="card-content"><table class="table table--small table--hover table--bordered"><tbody><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2026-05-13T22:00:00+00:00"
title="06:00:00 2026-05-13 pm EDT">
May. 13</span></td><td class="w-100"><a href="/news/medartis-holding-ag-completed-the-acquisition-of-cadskills-bv-ce7f5adfdb8cf120" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis Holding AG completed the acquisition of Cadskills Bv.
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="S&P Capital IQ"><span class="c-inline txt-align-center" style="width: 18px;">
CI
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2026-04-23T13:00:00+00:00"
title="09:00:00 2026-04-23 am EDT">
Apr. 23</span></td><td class="w-100"><a href="/news/medartis-holding-ag-elects-yang-xu-as-board-director-and-member-of-finance-and-audit-committee-ce7f59ded080f020" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis Holding AG Elects Yang Xu as Board Director and Member of Finance and Audit Committee
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="S&P Capital IQ"><span class="c-inline txt-align-center" style="width: 18px;">
CI
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2026-04-17T13:56:00+00:00"
title="09:56:00 2026-04-17 am EDT">
Apr. 17</span></td><td class="w-100"><a href="/news/straumann-holding-ag-announces-board-changes-ce7f59d9de8afe2c" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Straumann Holding AG Announces Board Changes
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="S&P Capital IQ"><span class="c-inline txt-align-center" style="width: 18px;">
CI
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2026-03-17T15:09:00+00:00"
title="11:09:00 2026-03-17 am EDT">
Mar. 17</span></td><td class="w-100"><a href="/news/medartis-holding-ag-reports-earnings-results-for-the-full-year-ended-december-31-2025-ce7e5ed8df8ff021" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis Holding AG Reports Earnings Results for the Full Year Ended December 31, 2025
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="S&P Capital IQ"><span class="c-inline txt-align-center" style="width: 18px;">
CI
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2026-03-17T11:35:59+00:00"
title="07:35:59 2026-03-17 am EDT">
Mar. 17</span></td><td class="w-100"><a href="/news/transcript-medartis-holding-ag-2025-earnings-call-mar-17-2026-ce7e5edbdf8fff20" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis Holding AG, 2025 Earnings Call, Mar 17, 2026
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="S&P Capital IQ"><span class="c-inline txt-align-center" style="width: 18px;"><i class="bi-mic-fill txt-negative"></i></span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2026-03-17T06:25:18+00:00"
title="02:25:18 2026-03-17 am EDT">
Mar. 17</span></td><td class="w-100"><a href="/news/medartis-logs-higher-fy25-net-income-revenue-ce7e5edbda8afe25" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis Logs Higher FY25 Net Income, Revenue
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="MT Newswires"><span class="c-inline txt-align-center" style="width: 18px;">
MT
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2026-03-17T05:52:43+00:00"
title="01:52:43 2026-03-17 am EDT">
Mar. 17</span></td><td class="w-100"><a href="/news/swiss-stocks-factors-to-watch-on-march-17-ce7e5edbda89ff25" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Swiss stocks - Factors to watch on March 17
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="Reuters"><span class="c-inline txt-align-center" style="width: 18px;">
RE
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2026-03-17T05:33:24+00:00"
title="01:33:24 2026-03-17 am EDT">
Mar. 17</span></td><td class="w-100"><a href="/news/medartis-builds-on-momentum-with-16-organic-sales-growth-and-core-ebitda-margin-exceeding-18-ce7e5edbdb80ff2c" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis 2025 organic core sales grow 15.7% to CHF 266.1 million
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="Reuters"><span class="c-inline txt-align-center" style="width: 18px;">
RE
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2026-03-16T23:00:00+00:00"
title="07:00:00 2026-03-16 pm EDT">
Mar. 16</span></td><td class="w-100"><a href="/news/medartis-holding-ag-signed-a-definitive-agreement-to-acquire-cadskills-bv-ce7f5adfdb8cf025" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis Holding AG signed a definitive agreement to acquire Cadskills Bv.
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="S&P Capital IQ"><span class="c-inline txt-align-center" style="width: 18px;">
CI
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2025-11-24T06:54:35+00:00"
title="01:54:35 2025-11-24 am EST">
Nov. 24</span></td><td class="w-100"><a href="/news/medartis-names-new-finance-chief-ce7d5edcda8cf12d" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis Names New Finance Chief
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="MT Newswires"><span class="c-inline txt-align-center" style="width: 18px;">
MT
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2025-11-24T06:02:35+00:00"
title="01:02:35 2025-11-24 am EST">
Nov. 24</span></td><td class="w-100"><a href="/news/medartis-appoints-peter-hackel-as-new-chief-financial-officer-ce7d5edcda8bf620" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis appoints Peter Hackel as new chief financial officer
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="Reuters"><span class="c-inline txt-align-center" style="width: 18px;">
RE
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2025-11-23T23:00:00+00:00"
title="06:00:00 2025-11-23 pm EST">
Nov. 23</span></td><td class="w-100"><a href="/news/medartis-holding-ag-announces-cfo-changes-ce7d51dade8df426" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis Holding AG Announces CFO Changes
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="S&P Capital IQ"><span class="c-inline txt-align-center" style="width: 18px;">
CI
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2025-08-19T21:21:58+00:00"
title="05:21:58 2025-08-19 pm EDT">
25-08-19</span></td><td class="w-100"><a href="/news/medartis-holding-ag-reports-earnings-results-for-the-half-year-ended-june-30-2025-ce7c51ddde8af226" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis Holding AG Reports Earnings Results for the Half Year Ended June 30, 2025
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="S&P Capital IQ"><span class="c-inline txt-align-center" style="width: 18px;">
CI
</span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2025-08-19T09:20:16+00:00"
title="05:20:16 2025-08-19 am EDT">
25-08-19</span></td><td class="w-100"><a href="/news/transcript-medartis-holding-ag-h1-2025-earnings-call-aug-19-2025-ce7c51dcd080fe26" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Medartis Holding AG, H1 2025 Earnings Call, Aug 19, 2025
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="S&P Capital IQ"><span class="c-inline txt-align-center" style="width: 18px;"><i class="bi-mic-fill txt-negative"></i></span></span></td></tr><tr class=" "><td class="table-child--centered table-child--top table-child--nowrap table-child--w60 txt-s1"><span class="js-date-relative txt-muted h-100 c-block px-5"
data-utc-date="2025-08-19T07:43:14+00:00"
title="03:43:14 2025-08-19 am EDT">
25-08-19</span></td><td class="w-100"><a href="/news/corporate-results-schedule-for-august-19-2025-ce7c51dcd08bff22" class="txt- txt-overflow-2 link link--no-underline my-5 my-m-0 ">
Corporate results schedule for August 19, 2025
</a></td><td class="table-child--right table-child--top table-child--w60 c-none cm-table"><span class="c-inline p-5 badge badge--small txt-s1" title="MarketScreener.com"><span class="c-inline txt-align-center" style="width: 18px;"><img src="https://cdn.zonebourse.com/images/logo_at.gif" width="14" height="8" alt="Zonebourse"></span></span></td></tr></tbody></table></div></div></div><div class="c-12 cm-4 "><div class="card mb-15"><div class="card-header"><h3 class="card-title"><a class="link" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/graphics/">
Chart Medartis Holding AG </a></h3></div><div class="card-content"><div class="grid mb-15"><div class="c-auto "><label for="bWCMois">Duration</label><selectchart_ta_42470802','duration',this.value)" id="bWCMois" class="ml-5 input"><option value="8" selected>Auto.</option><option value="2">2 months</option><option value="3">3 months</option><option value="6">6 months</option><option value="9">9 months</option><option value="12">1 year</option><option value="24">2 years</option><option value="60">5 years</option><option value="120">10 years</option><option value="9999">Max.</option></select></div><div class="c-auto "><label for="bWCPer">Period</label><selectchart_ta_42470802','cycle',this.value)" id="bWCPer" class="ml-5 input"><option value="DAY" selected>Day</option><option value="WEEK">Week</option></select></div></div><div class="txt-align-center media media--43 placeholder placeholder--w"><img id="chart_ta_42470802"
data-src="https://www.marketscreener.com/zbcache/charts/ObjectChart.aspx?Name=42470802&Type=Custom&Intraday=1&Width={width}&Height={height}&Cycle=DAY1&Duration={duration}&Render=Candle&ShowCopyright=2&ShowName=0&Locale=en&ShowVolume=1&Company=Skin:ZonebourseLight&externload="
src="data:image/gif;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs="
data-cycle="DAY1"
data-type="1"
alt="Chart Medartis Holding AG"
class="c-block js-responsive-ta-chart"
/></div></div><div class="card-footer"><a href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/graphics/"
class="more">
MED: Dynamic Chart
</a></div></div><div id="companyProfile" class="card mb-15 card--collapsible pos-next"><span class="js-collapse collapse" data-collapse="companyProfile"></span><div class="card-header"><h2 class="card-title"><a class="link" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/company/">
Company Profile
</a></h2></div><div class="card-content"><div><div class="mb-10 txt-justify txt-overflow-6"><div style="float:left;" class="mr-10"><img
height="30"
alt="Logo Medartis Holding AG"
none'"
src="https://cdn.zonebourse.com/static/instruments-squared-42470802.png"
></div>
Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. It has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.
</div><div class="grid pb-10 pb-m-5 border-top pt-5"><div class="c-3 txt-bold">Employees</div><div class="c-9 txt-align-right">
1,259
</div></div><div class="grid py-10 py-m-5 border-top txt"><div class="c-3 txt-bold">Sector</div><a class="c-9 txt-align-right link" href="/stock-exchange/sectors/healthcare/healthcare-services/?cf=ME5wTzZia2NKbTZkdlhjdDhhdGtyb1pnVFY4WDdvSjR6R0poRWdmMzg3bz0">
Medical Equipment, Supplies & Distribution
</a></div><div class="grid py-10 py-m-5 border-top txt"><div class="c-3 txt-bold">Calendar</div><div class="c-9 txt-align-right txt-inline"><a href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/calendar/" class="link">
Earnings release - Q2 2026
</a></div></div></div></div><div class="card-footer"><a href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/company/"
class="more">
More about the company
</a></div></div><div id="chart_right_ise_e_card" class="card card--collapsible mb-15 pos-next"><span class="js-collapse collapse" data-collapse="chart_right_ise_e_card"></span><div class="card-header"><h3 class="card-title"><a class="link" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/finances/">
Income Statement and Estimates
</a></h3></div><div class="card-content"><picture><source media="(max-width: 576px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 576px) and (max-width: 768px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 768px) and (max-width: 991px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 992px) and (max-width: 1260px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 1260px) and (max-width: 1400px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=NXlMWVoxUzNiUmVJZXhZSzZyemovWk1hR3JhWUd0c3JxdHhFb3AyMDFMMVNCY3E1TGhSOVNqcHU0Ti9MTUVRVXBFNkNobUJGdk9CSjh3SGtqaFhjdGdtOUowU0tDRnBCNnZhTDAxVnJWaDkvYnNqa0loQXZTSzRDdFZCRGpJVWk2YVFVN2E2QXFxUmNhZFBLSEhqUW1YMUFoTlNFRHRyQTBpa0kxdCtkanpTN0F0d1E0bG5lTmpmaldmV3ZabFVZTWdua2ZpZVl4Sll1ZHVuM3dyeWQydU1Wd21sT0ZEenluWi9sdC9ZbS8vOEM0U0dmVThUY2lBU0QzNzNkQTFnUGRxbzE3cTNxK2g1Nm8rdUcyeCs3NlpCNjRLem80WkYzeFlrRkthUFhDaUg1MjlJeXAxR3lIY0hDSFNJeVJKWHIrWDB0aGgyZ3NuUjFXdE92b1pqL1ZXeGZabE1hcTIrWHdNdXU1SDEyWFJRRVJ2ZnZQYnQ2RWhtQVB3Q2Z6U3dDM0lqZlJUb1NiS3lSNkh5cDFoL0FRclRxakc3WkllWk1iQkFNYmtPUm80SlpCZG1taGpHYWd6c20xeDJQS3pRTElGQXhaSEpiZWFwbmwrWXpIRGgvSzZpZGpUYlM4bjZHRS9PWERzTTloMjNtT3RKempoNElaMTFsRHNkUVNjMCtiU1ByU2FpZGNoSFpheWtGRjdKWDFRPT0"><source media="(min-width: 1400px) and (max-width: 1599px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><img src="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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" alt="" class='w-100' height='250' width='338'loading='lazy'loading")'></picture></div><div class="card-footer"><a href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/finances/"
class="more">
More financial data
</a></div></div><div id="ratings" class="card mb-15 card--collapsible pos-next"><span class="js-collapse collapse" data-collapse="ratings"></span><div class="card-header"><h3 class="card-title"><a class="link" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/ratings/">
Ratings
</a></h3></div><div class="card-content"><div><div class="grid py-5 border-bottom"><div class="c"><i class="bi-star-half pr-5"></i>Trader
</div><div class="c-auto px-5"><div class="dropdown-container c-inline"><span class="js_dropdown cursor-pointer c-inline " data-dropdown="#80noteDesc_4057"
data-dropdown-hover="true"><span class="badge badge--neutral"><i class="bi-info-circle"></i></span></span><div id="80noteDesc_4057" class="dropdown dropdown--wm250 "><div class="p-10"><p class="title txt-s2">Trader</p><p>This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.</p></div></div></div></div><div class="c-f90 txt-align-center"><span title="12%" class="star star--size2 v-align-middle"></span></div></div><div class="grid py-5 border-bottom"><div class="c"><i class="bi-star-half pr-5"></i>Investor
</div><div class="c-auto px-5"><div class="dropdown-container c-inline"><span class="js_dropdown cursor-pointer c-inline " data-dropdown="#80noteDesc_4058"
data-dropdown-hover="true"><span class="badge badge--neutral"><i class="bi-info-circle"></i></span></span><div id="80noteDesc_4058" class="dropdown dropdown--wm250 "><div class="p-10"><p class="title txt-s2">Investor</p><p>This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.</p></div></div></div></div><div class="c-f90 txt-align-center"><span title="15%" class="star star--size2 v-align-middle"></span></div></div><div class="grid py-5 border-bottom"><div class="c"><i class="bi-star-half pr-5"></i>Global
</div><div class="c-auto px-5"><div class="dropdown-container c-inline"><span class="js_dropdown cursor-pointer c-inline " data-dropdown="#80noteDesc_4049"
data-dropdown-hover="true"><span class="badge badge--neutral"><i class="bi-info-circle"></i></span></span><div id="80noteDesc_4049" class="dropdown dropdown--wm250 "><div class="p-10"><p class="title txt-s2">Global</p><p>This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.</p></div></div></div></div><div class="c-f90 txt-align-center"><span title="8%" class="star star--size1 v-align-middle"></span></div></div><div class="grid py-5 border-bottom"><div class="c"><i class="bi-star-half pr-5"></i>Quality
</div><div class="c-auto px-5"><div class="dropdown-container c-inline"><span class="js_dropdown cursor-pointer c-inline " data-dropdown="#80noteDesc_4050"
data-dropdown-hover="true"><span class="badge badge--neutral"><i class="bi-info-circle"></i></span></span><div id="80noteDesc_4050" class="dropdown dropdown--wm250 "><div class="p-10"><p class="title txt-s2">Quality</p><p>This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.</p></div></div></div></div><div class="c-f90 txt-align-center"><span title="16%" class="star star--size2 v-align-middle"></span></div></div><div class="grid py-5 "><div class="c"><i class="bi-star-half pr-5"></i>ESG MSCI
</div><div class="c-auto px-5"><div class="dropdown-container c-inline"><span class="js_dropdown cursor-pointer c-inline " data-dropdown="#80noteDesc_5546"
data-dropdown-hover="true"><span class="badge badge--neutral"><i class="bi-info-circle"></i></span></span><div id="80noteDesc_5546" class="dropdown dropdown--wm250 "><div class="p-10"><p class="title txt-s2">ESG MSCI</p><p>The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.</p></div></div></div></div><div class="c-f90 txt-align-center"><div class="esg-rank esg-rank--aa txt-bold txt-align-center">AA</div></div></div></div><picture><source media="(max-width: 576px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 576px) and (max-width: 768px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=NXlMWVoxUzNiUmVJZXhZSzZyemovWFdUbmdKdGxXa05IUEt3RXpxd2E2dDEyMGdEc2lGcTFrdDBhczk2T053bjZHQjk0ZDhtM2dOb0diRFkyN24wN01xTWdLc0kxSU5WV2doU3E5L3hHTkdUZFAyemlBNTVjUjd6NUdRQVMvNXFLSUpIUytYREJWeWh3Z2hwMXNsTVptU2dneWlMbHdFR0g5WFc0bFhxMTgyZWxzL2paekxSb0lkSWFyWXRQMHpzR3ltRXh3WThHTVB6U0dFTVBWeW9XaXhORXZIQjNRZDVSVkE2NnZ3aml0S2FTajNCbEVta29DbWVCUGkxM2FEVXhMZ2lBa1EzVERFQXJWWXNjSHhSb2NRcUFsdlNGMXdEcFJTd3RTYXZndElhbk9LL2cyaW5FVDYwZnR5dU1TbDVxMFBTbVpaS0NVQ1lSbFpWUWNlUWVGR1YyQzlhUWVjT3lzU3NXVFdiS2M4Y1ZNeFA5N0FhNW9SNkYrQmVYd0R4NlVlTHg4NFJDQVpONXRobUJKMTRvQW1uanNUb1NjNEFmb1VVRkFUUTRIOHRvMjJlMTdvVjVGTDFKUm56dS9MTTl4dUhySHl3NXh2Q0gxcEI0eGpSa0JnWktMcnArVE5SemQrcTEyUml1Q3cxd2p4OFY3M2M0ZS95Z1ZPK1U4WWZGSjlJQ3hZTW5lV2FENkowT3VCOUh0aC9pYmJ2SVlKMFJlaXh4QWJEZ2ZuM09ScysveDV6VUJUMEtHNmlxb2ovQWs3VkhVV1l0TzU0ZFRFRWk0U2FLYmV5OVJaWklrczZHZC9NaUpsMjdlOD0"><source media="(min-width: 768px) and (max-width: 991px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 992px) and (max-width: 1260px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 1260px) and (max-width: 1400px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=NXlMWVoxUzNiUmVJZXhZSzZyemovWFdUbmdKdGxXa05IUEt3RXpxd2E2dDEyMGdEc2lGcTFrdDBhczk2T053bjZHQjk0ZDhtM2dOb0diRFkyN24wN01xTWdLc0kxSU5WV2doU3E5L3hHTkdUZFAyemlBNTVjUjd6NUdRQVMvNXFLSUpIUytYREJWeWh3Z2hwMXNsTVptU2dneWlMbHdFR0g5WFc0bFhxMTgyZWxzL2paekxSb0lkSWFyWXRQMHpzR3ltRXh3WThHTVB6U0dFTVBWeW9XaXhORXZIQjNRZDVSVkE2NnZ3aml0S2FTajNCbEVta29DbWVCUGkxM2FEVVdldlkwNWRUSU9LM0szYzBUekJMUHk1MG1zS2YrcndIVFRkb05vZjBDRXJwUzJMc0RoWXY2VVdGZXpLR1c3ZDQzalZ0NlRORXhwOGRPK0tpWnBNMThIL3d6aXIrNFVCU0llNld0Mit6TG91TkUzOTUrQUpPbVp5cVF5bFFzUFpIajBMUDg3eTZWMnBuZW5xb2FuU01WT2F4WXpNcURSK1JydFh0cjQzQmlZVTk4QUlQWnAwazc3Q250ZVBJTWV3dWoxeE10clJNNHZhblhRb0svNmRXTUgyNEt4c2NuNCtXbU5BUTF4ZnJkeWtYYWpFYTl4cFdJM3RiaFAzZ3dnTUROYWxzRU5TV3Npdi9YU0c3bllCTjEyZE01Wkh3R1p4QlhGcEVGNHp5NWdKa0pLT3B6N2Q1TnorWGk5YW05a2V4SzhhNFdKejNCN0EzSUV2ZGJ5S3Brem1yMjRnUW9BZlNXb2FGZE42YjZUbz0"><source media="(min-width: 1400px) and (max-width: 1599px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><img src="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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" alt="" class='w-100' height='320' width='338'loading='lazy'loading")'></picture></div><div class="card-footer"><a href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/ratings/" class="more">More Ratings</a></div></div><div id="consensusDetail" class="card mb-15 card--collapsible pos-next"><span class="js-collapse collapse" data-collapse="consensusDetail"></span><div class="card-header c-flex gbetween"><h2 class="card-title"><a class="link" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/consensus/">
Analysts' Consensus
</a></h2></div><div class="card-content"><div><div class="txt-align-center my-10">Sell<div class="consensus-gauge" title="Rate: 7.5 / 10"><img style="padding-left:68.5px;" src="https://cdn.zonebourse.com/images/consensus_flch.gif" alt="Consensus"></div>Buy</div><div class="grid py-5"><div class="c">Mean consensus</div><div class="c-auto txt-align-right txt-bold">OUTPERFORM</div></div><div class="grid border-top py-5"><div class="c">Number of Analysts</div><div class="c-auto txt-align-right txt-bold">4</div></div><div class="grid border-top py-5"><div class="c">Last Close Price</div><div class="c-auto txt-align-right txt-bold"><span class="last "
>72.60</span>CHF</div></div><div class="grid border-top py-5"><div class="c">Average target price</div><div class="c-auto txt-align-right txt-bold"><span class="last "
>95.97</span>CHF</div></div><div class="grid border-top py-5"><div class="c">Spread / Average Target</div><div class="c-auto txt-align-right txt-bold"><span class="variation variation--pos no-animation txt-align-center c-block "
>+32.19%</span></div></div></div></div><div class="card-footer"><a href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/consensus/" class="more">Consensus</a></div></div><div id="chart_change_eps-cae" class="card card--collapsible mb-15 pos-next"><span class="js-collapse collapse" data-collapse="chart_change_eps-cae"></span><div class="card-header"><a class="card-title" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/consensus-revisions/">EPS Estimates</a></div><div class="card-content"><picture><source media="(max-width: 576px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=NXlMWVoxUzNiUmVJZXhZSzZyemovWkVwSnk5SHI1RytCaUs1MXhaKzQxS0hzNWRqMzJrRlFKaXY5SE12NVNSd252VkpaTzc5dXl4eWwvVjB0UmxCWWpGV3phWUJHSnUxaHZ5K1ZWZEVLL1pPNXExL2dFWXpOZS9zQyttMlFST25iY2cwVFM4Y2E5L0hIM3M4cmNiUU9QTEo1UmZJSlJmRzN6cm8vVkpuVXkxQ0pHTGJ5NWg4blBxMTN1U21GRzZGVG1LYTJBU1FuR0dMdXBaY1d4T2dRRnQvdG15aUg3VFFPSGJpTVdNVGFxQ3hnQzFXcnhka1dMc1VDMWpJalJrdjFLRllhdFdzZHJzWGNNQlpMakVXcXd1TG40WUp1cE5QcWdTaVhFc1JqMWJoODY2ZjRBN21lSjFUa2xOdEMxeEVDVW0rR01tdzJPSzl6aGJoQVNJSnhVWTN0eE9lanRENC9kaVpHU0t5YzJjUzAxeTFsdnpHbkV1OUpBN1N5TW9IUlZKWHVCeXZMN2FHSFlwWjUzY0c2cXJEQU1kL05zKzVYa05sSTdLYk5TQT0"><source media="(min-width: 576px) and (max-width: 768px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 768px) and (max-width: 991px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 992px) and (max-width: 1260px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 1260px) and (max-width: 1400px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 1400px) and (max-width: 1599px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><img src="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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" alt="" class='w-100' height='300' width='338'loading='lazy'loading")'></picture></div><div class="card-footer"><a class="more" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/consensus-revisions/">
Revisions to estimates
</a></div></div><div id="chart_qual_est" class="card card--collapsible pos-next mb-15"><span class="js-collapse collapse" data-collapse="chart_qual_est"></span><div class="card-header"><h3 class="card-title">Quarterly revenue - Rate of surprise</h3></div><div class="card-content"><picture><source media="(max-width: 576px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 576px) and (max-width: 768px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 768px) and (max-width: 991px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 992px) and (max-width: 1260px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 1260px) and (max-width: 1400px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><source media="(min-width: 1400px) and (max-width: 1599px)" srcset="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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"><img src="https://cdn.zonebourse.com/static/hes/MEDARTIS-HOLDING-AG_.svg?_=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" alt="" class='w-100' height='300' width='338'loading='lazy'loading")'></picture></div><div class="card-footer"><a class="more" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/calendar/">
Company calendar
</a></div></div></div></div><div class="mb-15 c-12 c-flex gcenter"><!-- Footer --><div class='zppAds'><div id='zppFooter'></div></div><script>
aAdsList.push('Footer');
aAdsListSize.push([[970, 250], [1000, 180], [1000, 200], [1000, 250]]);
aAdsListCA.push(null);
</script></div></main><div class="js-responsive-move-container c-none cl-block" data-move-id="rs_light_screen_content"><div class="js-responsive-move h-100" data-move-id="rs_light_screen_content" data-move-type="large"><aside class="c-none cm-block cm-f300 pt-5 h-100"><div class="rsidebar" style="margin:0;" ><script>
const RS_ASYNC = true;
</script><div class="rsidebar__component rsidebar__indexes mt-10 mt-m-0"><div class="rsidebar__indexes__menu px-5"><span data-tab="0" class="c js_rs__link link link--white rsidebar__indexes__menu__row rsidebar__indexes__menu__row--active"
><i class="bi-activity"></i> Indices</span><span data-tab="1" class="c js_rs__link link link--white rsidebar__indexes__menu__row "
>
Europe</span><span data-tab="2" class="c js_rs__link link link--white rsidebar__indexes__menu__row "
>
America</span><span data-tab="3" class="c js_rs__link link link--white rsidebar__indexes__menu__row "
>
Asia</span></div><div class="rsidebar__indexes__container"><div class="rsidebar__indexes__container__tab rsidebar__indexes__container__tab--active"><div class="txt-align-center px-m-5 p-5 my-10 bg-graph-intra-dark" style="height:116.8px"><div class="js_rs__graph placeholder" style="height:100px;width: 290px;"></div></div><div class="pb-10"><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div></div></div></div></div><div class="my-15"><!-- Right2 --><div class='zppAds'><div id='zppRight2'></div></div><script>
aAdsList.push('Right2');
aAdsListSize.push([300, 600]);
aAdsListCA.push(null);
</script></div><div id="rs-watchlist" class="mt-15"><div class="rsidebar__component pb-10"><div class="c-flex gbetween align-center p-10"><a href="/watchlist" class="rsidebar__title mt-0 txt-white">My Watchlist</a><div class="c ml-15 js-rs-watchlist placeholder">
</div></div><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div><hr /><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div></div><a href="/watchlist" class="c-block pl-0 py-5 txt-s2 more">My lists</a></div><div id="rs-palmares-0" class="mt-15"><div class="rsidebar__component pb-10"><div class="c-flex gbetween align-center p-10"><span class="rsidebar__title mt-0 txt-white placeholder">Rankings</span><div class="c ml-15 js-rs-watchlist placeholder">
</div></div><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div><hr /><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div><div class="pt-5"><div class="chart chart--h150 placeholder bg-black-primary"></div></div></div><a href="#"
class="c-block pl-0 py-5 txt-s2 more placeholder">
More Rankings
</a></div><div id="rs-palmares-1" class="mt-15"><div class="rsidebar__component pb-10"><div class="c-flex gbetween align-center p-10"><span class="rsidebar__title mt-0 txt-white placeholder">Rankings</span><div class="c ml-15 js-rs-watchlist placeholder">
</div></div><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div><hr /><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div><div class="pt-5"><div class="chart chart--h150 placeholder bg-black-primary"></div></div></div><a href="#"
class="c-block pl-0 py-5 txt-s2 more placeholder">
More Rankings
</a></div><div class="rsidebar__component js-rs-quotes mt-10 mt-m-0"><p class="rsidebar__title px-10 pt-10 pb-5 m-0">Currency / Forex</p><div class="txt-align-center px-m-5 p-5 bg-graph-intra-dark" style=""><div class="js_rs__graph placeholder" style="height:100px;width: 290px;"></div></div><div class="pb-10"><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div></div></div><div class="rsidebar__component js-rs-quotes mt-10 mt-m-0"><p class="rsidebar__title px-10 pt-10 pb-5 m-0">Commodities</p><div class="txt-align-center px-m-5 p-5 bg-graph-intra-dark" style=""><div class="js_rs__graph placeholder" style="height:100px;width: 290px;"></div></div><div class="pb-10"><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div></div></div><div class="rsidebar__component js-rs-quotes mt-10 mt-m-0"><p class="rsidebar__title px-10 pt-10 pb-5 m-0">Cryptocurrencies</p><div class="txt-align-center px-m-5 p-5 bg-graph-intra-dark" style=""><div class="js_rs__graph placeholder" style="height:100px;width: 290px;"></div></div><div class="pb-10"><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div></div></div><div class="rsidebar__component js-rs-quotes mt-10 mt-m-0"><p class="rsidebar__title px-10 pt-10 pb-5 m-0">Interest Rates</p><div class="txt-align-center px-m-5 p-5 bg-graph-intra-dark" style=""><div class="js_rs__graph placeholder" style="height:100px;width: 290px;"></div></div><div class="pb-10"><div class="quotation_table"><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div><div class="quotation_table__row px-5 placeholder"></div></div></div></div></aside></div></div></div><div class="bcrumb"><ol itemscope itemtype="https://schema.org/BreadcrumbList"><li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><a itemprop="item" itemid="https://www.marketscreener.com/" href="/"><span itemprop="name">Stock Market</span></a><meta itemprop="position" content="1"></li><li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><a itemprop="item" itemid="https://www.marketscreener.com/stock-exchange/shares/" href="/stock-exchange/shares/"><span itemprop="name">Equities</span></a><meta itemprop="position" content="2"></li><li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><a itemprop="item" itemid="https://www.marketscreener.com/quote/stock/MEDARTIS-HOLDING-AG-42470802/" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/"><span itemprop="name"> MED Stock
</span></a><meta itemprop="position" content="3"></li><li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><a itemprop="item" itemid="https://www.marketscreener.com/quote/stock/MEDARTIS-HOLDING-AG-42470802/news/" href="/quote/stock/MEDARTIS-HOLDING-AG-42470802/news/"><span itemprop="name">News Medartis Holding AG</span></a><meta itemprop="position" content="4"></li><li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><span itemprop="name">Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%</span><meta itemprop="position" content="4"></li></ol></div></div></div><footer><div class="container"><div class="grid gbetween align-center border-bottom--black mb-15 pb-15"><div class="pos-1 c c-none cs-block"><div class="txt-align-center"><img src="https://cdn.zonebourse.com/static/resize/40/40//images/services/2023/footer_logoass_portail.png" width="40" height="40"
alt="Best financial portal"
loading="lazy"
/></div><p class="m-0 txt-align-center txt-white txt-bold txt-s2 my-5">
Best financial<br/> portal
</p></div><div class="pos-3 c-6 cxs"><div class="txt-align-center"><img src="https://cdn.zonebourse.com/static/resize/40/40//images/services/2023/footer_logoass_2001_en.png" width="40" height="40"
alt="More than 20 yearsat your side"
loading="lazy"/></div><p class="m-0 txt-align-center txt-white txt-bold txt-s2 my-5">
More than 20 years<br/>at your side
</p></div><div class="c-6 cxs pos-5"><div class="txt-align-center js-l-obf cursor-pointer" data-tobf='blank' data-lobf="v4fox4ar=NToxCjOy4WEw2To=BbKwgTNnlnEnlxKwk0NvpjoxpbNnkjJnl6JmpTIdQboml8Odhiu"><img src="https://cdn.zonebourse.com/static/resize/106/48//static/images/footer/img_footer_trustpilot_4.png" loading="lazy" width="106" height="48" alt="Trustpilot"/></div></div><div class="c-6 cxs pos-3 pos-xs-7 mb-25 mb-s-0"><div class="txt-align-center"><img src="https://cdn.zonebourse.com/static/resize/40/40//images/services/2023/footer_logoass_membresl.png" width="40" height="40"
loading="lazy"
alt="+ 1,300,000members"/></div><p class="m-0 txt-align-center txt-white txt-bold txt-s2 my-5">
+ 1,300,000<br/>members
</p></div><div class="c c-none cs-block pos-6"><div class="txt-align-center"><img src="https://cdn.zonebourse.com/static/resize/40/40//images/services/2023/footer_logoass_resilitaion.png" width="40" height="40"
loading="lazy"
alt="Quick & easycancellation"/></div><p class="m-0 txt-align-center txt-white txt-bold txt-s2 my-5">
Quick & easy<br/>cancellation
</p></div><div class="c c-none cm-block pos-8"><div class="txt-align-center"><img src="https://cdn.zonebourse.com/static/resize/40/40//images/services/2023/footer_logoass_experts.png" width="40" height="40"
loading="lazy"
alt="Our Expertsare here for you"
/></div><p class="m-0 txt-align-center txt-white txt-bold txt-s2 my-5">
Our Experts<br/>are here for you
</p></div></div><div class="grid my-15 py-10 align-center"><div class="c-12 cs mr-auto c-flex align-center gcenter gs-start"><span class="js-l-obf cursor-pointer c-block cs-none cm-block" data-tobf='blank' data-lobf="v4fox4ar=NTq=BbKwgTbml8GnlfOmQ8AnkRAx9Zu"><i class="bi-twitter-x txt-white txt-s4 mr-15"></i></span><span class="js-l-obf cursor-pointer c-block cs-none cm-block" data-tobf='blank' data-lobf="v4fox4ar=NTQyQxJzkTPy4j7ngR9wpoKeZP5xBIAy0b9xBjAwBjN"><i class="bi-youtube txt-white txt-s4 mr-15"></i></span><span class="js-l-obf cursor-pointer c-block cs-none cm-block" data-tobf='blank' data-lobf="v4fox4ar=NTQyQxJvkROy20CxB0I=BbKwgTIml8GnlfOmQ8AnkRAxBTBnBA9vk0H=Luu"><i class="bi-instagram txt-white txt-s4 mr-15"></i></span><span class="js-l-obf cursor-pointer c-block cs-none cm-block" data-tobf='blank' data-lobf="v4fox4ar=NTQyQxJw2AJvpj/vkqJmpTI=pbKwlW5wC/Kwk0NvpjoxpbNnkjJnl6K"><i class="bi-linkedin txt-white txt-s4 mr-15"></i></span><span class="js-l-obf cursor-pointer c-block cs-none cm-block" data-tobf='blank' data-lobf="v4fox4ar=NTQyQxJy2AGy2TG=BbKwgTVwk0NvpjoxpbNnkjJnl6JmpTI"><i class="bi-tiktok txt-white txt-s4 mr-15"></i></span><span class="js-l-obf cursor-pointer" data-tobf='blank' data-lobf="v4fox4ar=NT5x4WO=B0Lx2MA=BbKwgTPxNT5x4VKwk0NvpjoxpbNnkjJnl6KvkePbOeOcYxochxu"><img src="https://cdn.zonebourse.com/static/images/footer/img_footer_appstore.png" alt="Download from Apple Store" loading="lazy"/></span></div><div class="c-12 cs-auto my-25 my-s-0"><div class="c-flex txt-white txt-s2 align-center gcenter"><div class="c"><p class="m-0">OUR EXPERTS ARE HERE FOR YOU</p><p class="m-0 txt-bold" >Monday - Friday 9am-12pm / 2pm-6pm GMT + 1</p></div><div class="pl-10 c-auto"><span class="js_modal_button" data-modal="contact-us" style="cursor:pointer;"><span class="btn btn--footer">Contact us</span></span><div id="contact-us" class="modal modal--large modal--no-refresh "
><span class="js_modal_close modal__close-btn"contact-us')"><i class="bi-x txt-s6 txt-black"></i></span><div class="modal__content h-100"><!--<iframe width="100%" class="media media--1610" src="/mods_a/popup/popup_contact.php"frameborder="0"></iframe>--></div></div></div></div></div><div class="c ml-auto txt-align-center txt-align-s-right"><div class="p-m-15 pr-10"><span class="js-l-obf cursor-pointer" data-lobf="=Luu"><img src="https://cdn.zonebourse.com/static/images/footer/footer_logo_ms.png" width="218" height="21" alt="MarketScreener, Stock Market Live" loading="lazy"/><span></div></div></div><div class="grid gcenter txt-footer mt-30"><span class="js-l-obf cursor-pointer c-auto" data-tobf='blank' data-lobf="=pMAnp0H=kRKy2A9neuu">
Legal information
</span><span class="c-none cs-inline ml-5 mr-5 c-auto">|</span><span class="cursor-pointer"
show', 2, console.log, {jumpAt: 'privacy'});">
Cookie settings
</span><span class="c-none cs-inline ml-5 mr-5 c-12 cs-auto" >|</span><span class="js-l-obf cursor-pointer c-auto" data-tobf='blank' data-lobf="=p8HwpxK">
MarketScreener Blog
</span><span class="c-none cs-inline ml-5 mr-5 c-12 cs-auto" >|</span><a href="/about-us" class="link txt-footer">
About us
</a><span class="c-none cs-inline ml-5 mr-5 c-12 cs-auto" >|</span><span class="c-block cs-inline txt-align-center" >
Copyright © 2026 Surperformance SAS. All rights reserved.
</span></div><div class="txt-align-center txt-footer mt-10">
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
</div></div></footer><script data-action="javascript-global-variable">
const GLOBAL_LOCALE = "en_US";
const GLOBAL_LANG = "en";
const GLOBAL_ISMOBILE = false;
const GLOBAL_TIMEZONE = "America/New_York"
const GLOBAL_XID = ""
const GLOBAL_ENV = 'PROD';
const GLOBAL_COLOR_SCHEME = 'light';
</script><script data-version='external' src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.7.1/jquery.min.js></script><script data-version='external' src=https://securepubads.g.doubleclick.net/tag/js/gpt.js></script><script data-version='external' id=xieg6Sie src=https://cdn.viously.com/js/sdk/boot.js></script><script data-version='external' src=https://cdnjs.cloudflare.com/ajax/libs/highcharts/12.3.0/highstock.min.js></script><script data-version='external' src=https://cdnjs.cloudflare.com/ajax/libs/highcharts/12.3.0/modules/treemap.min.js></script><script data-version='external' src=https://cdnjs.cloudflare.com/ajax/libs/highcharts/12.3.0/modules/heatmap.min.js></script><script data-version='external' src=https://cdnjs.cloudflare.com/ajax/libs/highcharts/12.3.0/highcharts-more.min.js></script><script data-version='external' src=https://cdn.appconsent.io/loader.js></script><script data-version='external' src=https://www.googletagmanager.com/gtag/js?id=G-W5MZBYLHSG></script><script data-version='external' src=https://cdnjs.cloudflare.com/ajax/libs/socket.io/4.8.1/socket.io.min.js></script><script data-version='external' src=https://accounts.google.com/gsi/client></script><script data-version='v1779441044' src="https://cdn.zonebourse.com/static/compiled-js/prod-1779441044-12250bd13a4782ac206952327ef0342d.min.js"></script><script>
__tcfapi('init', 2,
function() {
__tcfapi('show', 2, console.log, {jumpAt: 'banner',lazy: true});
__tcfapi("addEventListener", 2,
function (tcData, success) {
if(success && tcData.eventStatus === 'tcloaded' && tcData.addtlConsent === null) {
console.log("show CMP");
__tcfapi('show', 2, console.log);
}
}
);
},
{
appKey: '5eef9679-6e01-4486-8a2f-e0bdb1912916',
urlRedirect: {
main: {
denyAll : '/services/solutions/?utmzb_campaign=cmp++popin_cmp_refuser-s-abonner+refuser-s-abonner+&utmzb_content=++++&utmzb_source=popin&utmzb_medium=url_declenchement',
continueWithoutAccepting : '/services/solutions/?utmzb_campaign=cmp++popin_cmp_refuser-s-abonner+refuser-s-abonner+&utmzb_content=++++&utmzb_source=popin&utmzb_medium=url_declenchement',
},
settings : {
denyAll : '/services/solutions/?utmzb_campaign=cmp++popin_cmp_refuser-s-abonner+refuser-s-abonner+&utmzb_content=++++&utmzb_source=popin&utmzb_medium=url_declenchement',
}
},
}
)
</script><script data-action="{} Tags init"> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); function gaEvent(eventCategory, eventAction, eventLabel, eventValue) { var eventConf = {}; eventConf['send_to'] = 'G-W5MZBYLHSG'; if (typeof eventCategory !== 'undefined') eventConf['event_category'] = eventCategory; if (typeof eventLabel !== 'undefined') eventConf['event_label'] = eventLabel; if (typeof eventValue !== 'undefined') eventConf['value'] = eventValue; gtag('event',eventAction,eventConf); } </script><div id='div-gpt-ad-pixel' style="position:fixed;bottom:0;pointer-events: none"></div><script>
googletag.cmd.push(()=>{
googletag.defineSlot('/4093671/__pixel__', [1, 1], 'div-gpt-ad-pixel').addService(googletag.pubads())
googletag.pubads().enableSingleRequest();
googletag.enableServices();
})
</script><script type="text/javascript" src="https://try.abtasty.com/c08aeadc32b24da5aeee48542ac7879a.js"></script><script>
window.dataLayer = window.dataLayer || [];
window.dataLayer.push({
'userStatus': 'Gratuit',
});
</script><span class="js_modal_button" data-modal="user_data_modal" style="cursor:pointer;"></span><div id="user_data_modal" class="modal modal--large p-0 "
><div class="modal__content "></div><div class="modal__footer"></div></div><div class="esi_h" id="ud" style="width:0;margin:0;height:0;overflow:hidden;"><!-- bActiveMobileVersion 0 --><!-- bIsMobile 0 -->
<div
data-ga_event="onLinkClick"
data-ga_categorie="stats_teasing_click"
data-ga_action="868"
><div style="display:none;"
data-ga_event="onload"
data-ga_categorie="stats"
data-ga_action="teasing"
data-ga_libelle="868"></div><div style="display:none;"
data-ga_event="onload"
data-ga_categorie="sticky-btn-light"
data-ga_action="non-inscrit"
data-ga_libelle="sticky-btn-light_non-inscrits_trouvez-facilement_bg-bleu"></div><div id="t868" style="display:block"><div id="teasing_868" style="position:fixed;bottom:0;left:0px;width:100%;z-index:998;" >
<div style="align-items: start;display:flex;font-size: 0.9rem;padding:7px;background:#004eff;color:#ffffff;">
<div style="flex:1;display:flex;justify-content: center;">
<a target="_top" style="flex:1;display:flex;justify-content: center;text-decoration:none;color:inherit;"
href="/signup?utmzb_campaign=non-inscrits++sticky-btn-light_non-inscrits_trouvez-facilement_bg-bleu+trouvez-facilement_bg-bleu+&utmzb_content=++++&utmzb_source=sticky-btn-light&utmzb_medium=url_declenchement">
<div style="align-self: center;margin-right: 5px;">
<span style="
">
As early as today, start finding the best investment opportunities! </span>
<span class="c-inline cs-none" >
<div style="
color:#ffffff; font-weight:700; ">
Optimize my profits </div>
</span>
</div>
<div class="c-none cs-block" >
<div style="
box-shadow:1px 1px 2px #5c5c5c; padding:3px 15px; color:#000000; background:#ffffff; margin:0px 0px 0px 15px; ">
Optimize my profits </div>
</div> </a>
</div>
<div class="ajax_close_teasing868" style="padding:0px 10px;">
<svg
class="bi bi-x-circle-fill "
xmlns="http://www.w3.org/2000/svg" style="margin-top:5px;cursor:pointer;margin-left:auto;width:20px;" fill="white" alt="fermer"
viewBox="0 0 16 16">
<path
data-idteasing="868"
class="ajax_close_teasing868"
d="M16 8A8 8 0 1 1 0 8a8 8 0 0 1 16 0zM5.354 4.646a.5.5 0 1 0-.708.708L7.293 8l-2.647 2.646a.5.5 0 0 0 .708.708L8 8.707l2.646 2.647a.5.5 0 0 0 .708-.708L8.707 8l2.647-2.646a.5.5 0 0 0-.708-.708L8 7.293 5.354 4.646z"/>
</svg>
</div>
</div>
</div>
<script>
document.addEventListener("click", function(event) {
if (event.target.matches(".ajax_close_teasing868")) {
var element = event.target;
var xhr = new XMLHttpRequest();
xhr.open("GET", "/mods_a/ajax_teasing.php?action=hide&idT="+element.getAttribute('data-idteasing'), true);
xhr.setRequestHeader("Content-Type", "application/json");
xhr.onreadystatechange = function() {
if (xhr.readyState === 4 && xhr.status === 200) {
element.closest('[id*="teasing_"]').remove();
}
};
xhr.send();
}
});
document.addEventListener("click", function(event) {
if (event.target.matches(".ajax_close_teasing_ws868")) {
var element = event.target;
element.closest('[id*="teasing_"]').remove();
}
});
</script>
</div></div></div><script>
function onloadUI()
{
}
function onunloadUI()
{
}
</script>
<script>var country_location = "IN";
function startAdsServiceD(){
gaEvent('adspv', 'internal_start', 'IN');
$(document).ready(function() {
displayViewableAds('internal');
$( window ).scroll(function() {
displayViewableAds('internal');
});
});
}
$(document).ready(function() {gaEvent('adspv', 'internal', 'IN');});
googletag.cmd.push(function() {
googletag.pubads().setTargeting('Edition', 'en_US');
googletag.pubads().setTargeting('UserType', 'free');
googletag.pubads().setTargeting('Content', 'equities');
googletag.pubads().setTargeting('codezb', '42470802');
var iAdsPos = 0; aAdsList.forEach(function(e) { if (aAdsListSize[iAdsPos] !== null && (aAdsListCA[iAdsPos] === null || aAdsListCA[iAdsPos] == country_location)) { googletag.defineSlot('/4093671/_'+e+'_/internal_'+e, aAdsListSize[iAdsPos], 'zpp'+e).addService(googletag.pubads());}iAdsPos++;});
googletag.enableServices();
var iAdsPos = 0; aAdsList.forEach(function(e) { if (aAdsListSize[iAdsPos] !== null && (aAdsListCA[iAdsPos] === null || aAdsListCA[iAdsPos] == country_location)) { googletag.display('zpp'+e); }iAdsPos++;});
try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}
});
$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });
</script> </div><script async defer src="https://ats-wrapper.privacymanager.io/ats-modules/7b190444-c935-406d-8261-160ca079fd9a/ats.js"></script><script data-action="{} Tags usage" data-version="3" data-type="cached">
gtag('config', 'G-W5MZBYLHSG', { 'anonymize_ip': true, 'page_path': "/quote/stock/MEDARTIS-HOLDING-AG-42470802/news/Medartis-delivers-12-core-sales-growth-in-2024-and-improves-its-core-EBITDA-margin-from-17-to-19-49356912/"
, 'content_group1': 'Actions' , 'content_group2': 'eqs' , 'content_group3': 'action/communique_de_presse' });
</script><script data-action="live-opts">
const liveHtml_BASE_URL = "https://live.marketscreener.com";
const liveHtml_AUTH = { hkKey: "9bf098266975e4c743f0825f85a5fa08", pvKey: "8a2447b92741c59e05c136c8c32231a4", uKey:"L3F1b3RlL3N0b2NrL01FREFSVElTLUhPTERJTkctQUctNDI0NzA4MDIvbmV3cy9NZWRhcnRpcy1kZWxpdmVycy0xMi1jb3JlLXNhbGVzLWdyb3d0aC1pbi0yMDI0LWFuZC1pbXByb3Zlcy1pdHMtY29yZS1FQklUREEtbWFyZ2luLWZyb20tMTctdG8tMTktNDkzNTY5MTIv" };
const liveHtml_TOJS = [];
</script><div id="editionModal" class="modal modal--large "><span class="js_modal_close modal__close-btn"editionModal')"><i class="bi-x txt-s7 txt-black"></i></span><div class="modal__content"><div class="modal_title-custom pt-15"><div class="grid align-center"><i class="pl-10 bi-globe2 globe-icon c-none cm-inline"></i><div><p class="pl-10 txt-bold m-0">Select your edition</p><p class="txt-s1 txt-muted m-0 pl-10">All financial news and data tailored to specific country editions</p></div></div></div><div class="grid mb-5 mt-15"><div class="c-12 cm-3 c-flex gcol gbetween"><div class="mb-10"><p class="region-title pl-5 mb-10">NORTH AMERICA</p><div class="c-flex flex-wrap countries-grid--1"><a class="country-item align-center active" data-edition="en_US" href="/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/us.png" loading="lazy" alt="MarketScreener"></div><span class="country-name">United-States</span></a><a class="country-item align-center " data-edition="en_CA" href="//ca.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/ca.png" loading="lazy" alt="MarketScreener Canada"></div><span class="country-name">Canada</span></a></div></div><div class="mb-10"><p class="region-title pl-5 mb-10">MIDDLE EAST</p><div class="c-flex flex-wrap countries-grid--1"><a class="country-item align-center " data-edition="en_SA" href="//sa.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/sa.png" loading="lazy" alt="MarketScreener Saudi Arabia"></div><span class="country-name">Saudi Arabia</span></a><a class="country-item align-center " data-edition="en_AE" href="//ae.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/ae.png" loading="lazy" alt="MarketScreener UAE Emirates"></div><span class="country-name">United Arab Emirates</span></a></div></div></div><div class="c-12 cm-6 "><div class="mb-10"><p class="region-title pl-5 mb-10">EUROPE</p><div class="c-flex flex-wrap countries-grid--2"><a class="country-item align-center " data-edition="fr_FR" href="//www.zonebourse.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/fr.png" loading="lazy" alt="Zonebourse"></div><span class="country-name">France</span></a><a class="country-item align-center " data-edition="de_DE" href="//de.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/de.png" loading="lazy" alt="MarketScreener Deutschland"></div><span class="country-name">Deutschland</span></a><a class="country-item align-center " data-edition="fr_CH" href="//ch.zonebourse.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/ch.png" loading="lazy" alt="Zonebourse Suisse"></div><span class="country-name">Suisse</span></a><a class="country-item align-center " data-edition="de_CH" href="//ch.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/ch.png" loading="lazy" alt="MarketScreener Schweiz"></div><span class="country-name">Schweiz</span></a><a class="country-item align-center " data-edition="it_IT" href="//it.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/it.png" loading="lazy" alt="MarketScreener Italia"></div><span class="country-name">Italia</span></a><a class="country-item align-center " data-edition="de_AT" href="//at.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/at.png" loading="lazy" alt="MarketScreener Österreich"></div><span class="country-name">Österreich</span></a><a class="country-item align-center " data-edition="nl_BE" href="//be.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/be.png" loading="lazy" alt="MarketScreener België"></div><span class="country-name">België</span></a><a class="country-item align-center " data-edition="nl_NL" href="//nl.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/nl.png" loading="lazy" alt="MarketScreener Nederland"></div><span class="country-name">Nederland</span></a><a class="country-item align-center " data-edition="es_ES" href="//es.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/es.png" loading="lazy" alt="MarketScreener España"></div><span class="country-name">España</span></a><a class="country-item align-center " data-edition="sv_SE" href="//se.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/se.png" loading="lazy" alt="MarketScreener Sverige"></div><span class="country-name">Sverige</span></a><a class="country-item align-center " data-edition="en_GB" href="//uk.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/gb.png" loading="lazy" alt="MarketScreener UK"></div><span class="country-name">United Kingdom</span></a></div></div></div><div class="c-12 cm-3 "><div class="mb-10"><p class="region-title pl-5 mb-10">APAC</p><div class="c-flex flex-wrap countries-grid--1"><a class="country-item align-center " data-edition="en_AU" href="//au.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/au.png" loading="lazy" alt="MarketScreener Australia"></div><span class="country-name">Australia</span></a><a class="country-item align-center " data-edition="en_IN" href="//in.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/in.png" loading="lazy" alt="MarketScreener India"></div><span class="country-name">India</span></a><a class="country-item align-center " data-edition="en_HK" href="//hk.marketscreener.com/"><div class="country-flag"><img src="https://cdn.zonebourse.com/images/png-country/24x24/hk.png" loading="lazy" alt="MarketScreener Hong Kong"></div><span class="country-name">Hong Kong</span></a></div></div></div></div></div></div><div id="notifications-portal"
data-flashes="[]"
></div><div id="g_id_onload"
data-client_id="420803176712-vlrh8sjg6d8d2ljv2t5o05foig31q9qd.apps.googleusercontent.com"
data-login_uri="https://www.marketscreener.com/login/google/"
data-auto_prompt="true"
data-itp_support="true"
></div><script src="https://cdn.zonebourse.com/static/assets/mPulse/mpulse-surperformance.js" async></script><input type="hidden" id="csrf-token" value="6bb76b69acb6b83488587548874.GqbEXNnsEr-muzaPYtU8mxCtZC_wfYpGdxmSGjOv8-E.LpGIK66pVtGRwUG2CIcJtnTKUnWIFvwkAmHdRVfnp5Iqla8b69Qg7sXSVQ"></body></html> |